Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment.
Cazzola
M
M
Guarnone
R
R
Cerani
P
P
Rovati
A
A
Ascari
E
E
D000241:Adenosine / Q000502:physiology; D000293:Adolescent; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000097:blood* / Q000502:physiology; D005260:Female; D006801:Humans; D011086:Polycythemia / Q000097:blood / Q000151:congenital / Q000188:drug therapy*; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1 / Q000502:physiology; D011990:Receptors, Transferrin / Q000097:blood*; D015290:Second Messenger Systems / Q000187:drug effects / Q000502:physiology; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use*
D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; D011990:Receptors, Transferrin; D004921:Erythropoietin; D013806:Theophylline; D000241:Adenosine